Age-related treatment patterns for stage I NSCLC in three European countries

Francisci, 2015, Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study, Eur J Cancer, 51, 2242, 10.1016/j.ejca.2015.07.033 Walters, 2013, Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007, Thorax, 68, 551, 10.1136/thoraxjnl-2012-202297 Khakwani, 2015, The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery, Thorax, 70, 146, 10.1136/thoraxjnl-2014-205841 Postmus, 2017, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, iv1, 10.1093/annonc/mdx222 Guckenberger, 2017, ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer, Radiother Oncol, 124, 11, 10.1016/j.radonc.2017.05.012 Baldwin, 2018, British Thoracic Society quality standards for the investigation and management of pulmonary nodules, BMJ Open Respir Res, 5, 10.1136/bmjresp-2017-000273 Ball, 2019, Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial, Lancet Oncol, 20, 494, 10.1016/S1470-2045(18)30896-9 Nyman, 2016, SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC, Radiother Oncol, 121, 1, 10.1016/j.radonc.2016.08.015 Dahele, 2015, Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries, Acta Oncol, 54, 1237, 10.3109/0284186X.2014.1003961 McAleese, 2017, The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung Cancer, Clin Oncol, 29, 593, 10.1016/j.clon.2017.06.014 Haque, 2018, Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer, Radiother Oncol, 129, 264, 10.1016/j.radonc.2018.07.008 Islam, 2016, Lung cancer radiation therapy in Australia and New Zealand: Patterns of practice, J Med Imaging Radiat Oncol, 60, 677, 10.1111/1754-9485.12475 Palma, 2010, Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis, J Clin Oncol, 28, 5153, 10.1200/JCO.2010.30.0731 Jain, 2013, Stereotactic ablative radiotherapy in the UK: current status and developments, Br J Radiol, 86, 20130331, 10.1259/bjr.20130331 Brustugun, 2018, Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016, Lung Cancer, 122, 138, 10.1016/j.lungcan.2018.06.003 Cancer registry of Norway Graham, 2016, Return of the pulmonary nodule: the radiologist’s key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules, Br J Radiol, 89, 2010776, 10.1259/bjr.20150776 Khakwani, 2017, Apples and pears? A comparison of two sources of national lung cancer audit data in England, ERJ Open Res, 3, 00003, 10.1183/23120541.00003-2017 Larsen, 2009, Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness, Eur J Cancer, 45, 1218, 10.1016/j.ejca.2008.10.037 Haasbeek, 2012, Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands, Ann Oncol, 23, 2743, 10.1093/annonc/mds081 Hopmans, 2015, Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment, Radiother Oncol, 115, 361, 10.1016/j.radonc.2015.05.006 Koshy, 2015, Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis, J Thorac Oncol, 10, 264, 10.1097/JTO.0000000000000418 Radovic, 2019, Multidisciplinary treatment of lung cancer in older patients: A review, J Geriatr Oncol, 10, 405, 10.1016/j.jgo.2018.09.005 Franks, 2020, SABRTOOTH: A randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection, Eur Respir J, 56, 2000118, 10.1183/13993003.00118-2020 Paul, 2016, Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis, BMJ, 354, i3570, 10.1136/bmj.i3570 Chen, 2018, Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies, Int J Radiat Oncol Biol Phys, 101, 186, 10.1016/j.ijrobp.2018.01.064 Herder, 2005, Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography, Chest, 128, 2490, 10.1378/chest.128.4.2490 Phillips, 2019, Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer, Clin Oncol, 31, 681, 10.1016/j.clon.2019.07.013 Solberg, 2019, Increase in curative treatment and survival of lung cancer in Norway 2001-2016, Eur J Epidemiol, 34, 951, 10.1007/s10654-019-00536-z Driessen, 2019, Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older, J Geriatr Oncol, 10, 547, 10.1016/j.jgo.2019.03.001